Found: 18
Select item for more details and to access through your institution.
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus.
- Published in:
- Dermatology Reports, 2023, v. 15, n. 2, p. 39, doi. 10.4081/dr.2023.9613
- By:
- Publication type:
- Article
Long‐term efficacy and safety of apremilast in psoriatic arthritis: Focus on skin manifestations and special populations.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 3, p. 1, doi. 10.1111/dth.13440
- By:
- Publication type:
- Article
Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 9, p. 1, doi. 10.2340/00015555-3846
- By:
- Publication type:
- Article
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 3, p. 1, doi. 10.2340/00015555-3712
- By:
- Publication type:
- Article
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1017, doi. 10.1111/jdv.18913
- By:
- Publication type:
- Article
Risankizumab: Daily Practice Experience of High Need Patients.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1769, doi. 10.3390/biomedicines11061769
- By:
- Publication type:
- Article
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102522
- By:
- Publication type:
- Article
Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5204, doi. 10.3390/jcm11175204
- By:
- Publication type:
- Article
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 16, p. 4778, doi. 10.3390/jcm11164778
- By:
- Publication type:
- Article
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 2551, doi. 10.2147/PPA.S326498
- By:
- Publication type:
- Article
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 847, doi. 10.2147/CCID.S400520
- By:
- Publication type:
- Article
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 27, doi. 10.2147/CCID.S378135
- By:
- Publication type:
- Article
A rare skin infection in atopic dermatitis: A case report.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 2945, doi. 10.1002/ccr3.3167
- By:
- Publication type:
- Article
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 11, p. 2613, doi. 10.1007/s13555-022-00797-9
- By:
- Publication type:
- Article
Update on the Management of Pediatric Psoriasis: An Italian Consensus.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 8, p. 1753, doi. 10.1007/s13555-022-00758-2
- By:
- Publication type:
- Article
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 6, p. 671, doi. 10.1007/s40272-022-00531-0
- By:
- Publication type:
- Article